{"result": {"id": "chatcmpl-319", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"The Vascular Health Research Community\",\n    \"summary\": \"This report explores the interconnected entities within the 'Vascular Health Research Community', focusing on their roles, relationships, and significant contributions to advancing vascular health research. The community comprises researchers, clinicians, and organizations dedicated to understanding and treating vascular diseases.  Their work spans from basic science discoveries to clinical trials and patient care, all aimed at improving outcomes for individuals affected by vascular conditions.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The Vascular Health Research Community exhibits a high level of impact due to its significant contributions to the field of vascular health research. The community's collective efforts have led to advancements in understanding and treating various vascular diseases, impacting patient care and potentially saving lives.\",\n    \"findings\": [\n        {\n            \"summary\": \"The community is driven by a shared goal of improving vascular health through research and innovation.\",\n            \"explanation\": \"This community's core purpose is to advance the field of vascular health. This is achieved through collaborative efforts, including: \\n* **Research:**  Conducting studies on various aspects of vascular diseases, from cellular mechanisms to clinical trials.\\n* **Innovation:** Developing new technologies and therapies for treating vascular conditions.\\n* **Education:** Training future generations of researchers and clinicians in the field.\\n* **Collaboration:** Fostering partnerships between researchers, clinicians, and industry stakeholders. \\nThis collective effort fuels progress towards better understanding and treatment options for patients with vascular diseases.\"\n        },\n        {\n            \"summary\": \"The community's research efforts are supported by a diverse range of funding sources.\",\n            \"explanation\": \"Funding is crucial to support the ongoing research within this community.  It comes from various sources, including: \\n* **Government agencies:** Funding bodies like the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA). \\n* **Private foundations:** Foundations dedicated to supporting medical research.\\n* **Industry partnerships:** Companies developing new technologies or therapies for vascular diseases. \\n* **Individual donations:**  Supporters who contribute financially to support research efforts.\"\n        },\n        {\n            \"summary\": \"The community's impact extends beyond the laboratory and clinic, influencing policy and public health initiatives.\",\n            \"explanation\": \"This community plays a vital role in shaping policies and public health initiatives related to vascular diseases.  Their work influences: \\n* **Public awareness campaigns:** Raising awareness about the importance of vascular health and prevention strategies.\\n* **Regulatory guidelines:** Developing standards for clinical trials and research protocols.\\n* **Healthcare policy:** Advocating for policies that improve access to care and support for patients with vascular diseases.\"\n        },\n        {\n            \"summary\": \"The community's success relies on the collaboration of diverse stakeholders.\",\n            \"explanation\": \"Collaboration is key to achieving impactful results within this community.  It involves: \\n* **Researchers:** Scientists, clinicians, and engineers working together to develop new solutions.\\n* **Clinicians:** Doctors and nurses providing patient care and clinical expertise.\\n* **Patients:** Individuals affected by vascular diseases who contribute their experiences and insights.\\n* **Industry partners:** Companies developing new technologies and therapies for vascular diseases. \\n* **Government agencies:**  Organizations that provide funding, regulatory oversight, and policy support.\"\n        },\n        {\n            \"summary\": \"The community's future direction will be shaped by emerging trends in research and technology.\",\n            \"explanation\": \"The community is poised to make significant advancements in the coming years.  Key areas of focus include: \\n* **Personalized medicine:** Tailoring treatments based on individual patient characteristics.\\n* **Artificial intelligence (AI):** Using AI to analyze large datasets and identify new insights.\\n* **Bioengineering:** Developing innovative solutions for vascular repair and regeneration.\\n* **Telemedicine:** Expanding access to care through remote consultations and monitoring.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743143043, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 830, "prompt_tokens": 2048, "total_tokens": 2878, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n4296,PATHOLOGIES,Conditions related to abnormal blood vessel growth,3\n4826,AML,,2\n192,ELISA,\"The **ELISA** method is a technique used to measure protein expression levels. It is an enzyme-linked immunosorbent assay (ELISA) that can be used to detect the expression levels of various proteins, including VEGF.  Specifically, ELISA has been employed to evaluate the level of VEGFA secretion from BV2 cells and to measure the contents of IL-1β, IL-18, and VEGFA in cell culture. \n\",2\n4824,H22954,Long non-coding RNA H22954,12\n1121,INVASION,Technique used in a chain of experiments,4\n3300,LRG1,,16\n1471,DIABETIC WOUNDS,Diabetic wounds are the subject of this study,3\n3303,WNT/Β-CATENIN PATHWAY,Pathway involved in wound healing,1\n3304,WOUND CLOSURE,,1\n4109,PANCREATIC CANCER,Pancreatic cancer is a type of cancer,1\n4112,CELL INVASION,,1\n4114,IL-18,Interleukin-18 is a cytokine,1\n918,SOTAILGFLOSIN,Sotagliflozin is a SGLT2 inhibitor,6\n921,PROLIFERATION,,8\n4415,CRART16,A novel lncRNA that could induce cetuximab resistance in colorectal cancer cells,8\n1839,GASTRIC CANCER,\"Gastric cancer is a type of cancer that affects the stomach. It is also a type of cancer studied in medical research and is classified as such. \n\",6\n4799,HRMEC,Human retinal microvascular endothelial cells,6\n4827,AML SAMPLES,,2\n909,HIGH GLUCOSE,,8\n559,HYPOXIA,\"The **hypoxia** condition refers to a state of low oxygen levels in the body's tissues.  It can be characterized by air composition with 1.2% oxygen and 5% carbon dioxide, balanced with nitrogen (N<sub>2</sub>). This imbalance leads to a lack of sufficient oxygen for proper cellular function, resulting in various health complications. \n\",5\n4791,PTX3,Protein being studied in the experiment,7\n473,HRMECS,Human retinal microvascular endothelial cells,6\n4828,DUAL-LUCIFERASE REPORTER GENE ASSAY,,1\n4829,HALF-LIFE ASSAY,,1\n1815,CELL LINES,\"**Cell lines** are cell cultures used for study and research, particularly in the field of **gastric cancer**.  They are employed to investigate various aspects of this disease. \n\",4\n4148,COX-2,\"The **COX-2** gene encodes for a protein called cyclooxygenase-2 (COX-2), an enzyme that plays a crucial role in the production of prostaglandins.  Prostaglandins are lipid mediators involved in various physiological processes, including inflammation and pain response.  Detection of COX-2 gene silencing was confirmed using Western blot analysis. \n\",9\n920,CELL VIABILITY,,6\n4147,ENDOTHELIAL TP,Endothelial TP is a protein that plays a role in angiogenesis,2\n4150,IN VIVO ANGIOPGENESIS ASSAYS,,2\n4978,HYPOXIC CONDITIONS,Conditions where oxygen levels are low,3\n103,MIGRATION,\"**Migration** refers to the movement of cells, which can be observed in various contexts.  It is also a technique employed in scientific experiments, particularly within a chain of experiments, and specifically involves the movement of endothelial cells. \n\",8\n906,DIABETIC CONDITIONS,Conditions associated with reduced EPC function,2\n4424,VEGFD,Gene involved in angiogenesis,2\n4800,PTX3 SIRNA,Gene silencing via siRNA,2\n1174,CELL CULTURE,,4\n4110,BXPC-3,\"The **BXPC-3** cell line is a pancreatic cancer cell line used in research and studies. It is also commonly referred to as a cell line used in the study of pancreatic cancer. \n\",3\n4111,CAPAN-2,\"The **CAPAN-2** cell line is a pancreatic cancer cell line widely used in research. It has been employed in studies investigating various aspects of pancreatic cancer, including its biology and potential treatment strategies.  This cell line is also commonly referred to as a \"\"cell line used for research\"\" and \"\"cell line used in the study.\"\" \n\",3\n4423,GASTRIC CANCER CELLS,,1\n4420,MIR-122-5P,A microRNA that is being studied for its effects on gastric cancer,1\n4797,TUBE-FORMING ABILITY,,2\n2575,METTL3,\"**METTL3** is a protein that acts as an **enzyme** called a **methyltransferase**. It plays a crucial role in **RNA modification**, specifically by catalyzing the addition of methyl groups to RNA molecules.  This process, known as RNA methylation, can influence various cellular processes and functions. \n\",2\n4792,FGF,Growth factor that is being tested,1\n4795,KI67 IMMUNOFLUORESCENT STAINING,,1\n4796,ERK PHOSPHORYLATION,,1\n4798,FIBROBLAST GROWTH FACTOR (FGF)-INDUCED PROLIFERATION,,1\n4977,HUMAN ADIPOSE-DERIVED STEM CELLS,hADSCs are stem cells that can be harvested and multiplied in lab cultures,3\n1252,STEM CELLS,\"**STEM CELLS** are a crucial component of both tissue engineering and regenerative medicine.  They are a unique type of cell capable of developing into various other cell types, allowing them to play a significant role in research and medicine. Stem cells possess the remarkable ability to divide and form new cells, making them essential for numerous applications. These cells are actively used in treatments and hold immense potential for future medical advancements. \n\",5\n919,C2C12 SKELETAL MUSCLE CELLS,Cells used in the study of sotagliflozin's effects on angiogenesis,1\n1173,IN VITRO STUDY,\"An **in vitro study** is a scientific experiment conducted on cells in a controlled laboratory environment.  These studies are designed to investigate various biological responses, such as cytotoxicity (cell death), inflammatory response, and angiogenesis (formation of new blood vessels). In the context of silicone gel breast implants, an in vitro study might examine how different textured surfaces of the implants affect these cellular processes. \n\",2\n2342,CELL COUNTING KIT-8 (CCK-8),Assay used to measure cell viability,1\n4151,ANGIOGENIC CAPACITY,,5\n4793,SCRATCH-WOUND MIGRATION ASSAY,,1\n4794,TUBE FORMATION EXPERIMENTS,,1\n4801,TUBE-FORMING,,1\n2039,PDGFA,\"The **PDGF** (Platelet-Derived Growth Factor) family of proteins plays a crucial role in various biological processes, including cell growth and development.  Specifically, **PDGF-alpha** is a member of this family and is known for its involvement in cell growth and repair. Additionally, PDGF has been implicated in the regulation of acute myeloid leukemia (AML). \n\",3\n4991,REGENERATIVE THERAPY,A field of study and treatment in medicine,2\n1888,BLOOD VESSEL FORMATION,\"**Blood vessel formation** is a biological process that is influenced by factors such as **supraphysiological testosterone levels**. \n\",1\n4992,ANGIOGENIC GROWTH FACTORS,Growth factors are proteins that stimulate the growth of blood vessels,3\n4993,ANGIOGENIC THERAPEUTICS,Treatments that use angiogenic properties to improve outcomes,4\n4994,PROCEDURES,,2\n1176,PROLILYL,,1\n905,ENDOTHELIAL PROGENITOR CELLS,Cells that repair damaged vessels and trigger ischemic angiogenesis,2\n3298,LOWER EXTREMITY AMPUTATION,A potential outcome of diabetic wounds,1\n3299,DEATH,A potential outcome of diabetic wounds,1\n4146,LIPID MEDIATOR,Lipid mediator profiling is a research method,2\n4421,FOS,\"A protein involved in cell growth and proliferation, which is being studied for its role in gastric cancer\",2\n2576,ADAMTS9,\"The **ADAMTS9** enzyme plays a role in the progression of **GC**, acting as a downstream effector of **METTL3**. \n\",1\n4149,FUNCTIONAL CELL ANALYSIS,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1657,ANGIOGENESIS,PATHOLOGIES,Angiogenesis is a factor in many diseases,149\n1898,ANGIOGENESIS,AML,Acute myeloid leukemia is associated with angiogenesis,148\n1465,VEGF,ELISA,ELISA can detect VEGF,36\n1899,H22954,TUMOR GROWTH,lncRNA H22954 inhibits tumor growth,26\n797,TUMOR,INVASION,Tumor invasion is influenced by long non-coding RNAs,25\n1269,LRG1,WOUND HEALING,LRG1 is essential for timely wound healing,25\n1266,DIABETIC WOUNDS,LRG1,LRG1 may play a role in regulating angiogenesis in diabetic wounds,19\n1271,WNT/Β-CATENIN PATHWAY,LRG1,LRG1 activates the Wnt/β-catenin pathway to promote wound closure in diabetic wounds,17\n1273,LRG1,WOUND CLOSURE,LRG1 promotes wound closure by activating the Wnt/β-catenin pathway,17\n1594,LRG1,PANCREATIC CANCER,LRG1 is involved in pancreatic cancer pathogenesis,17\n1601,LRG1,CELL INVASION,LRG1 affects cell invasion,17\n1606,LRG1,IL-18,LRG1 overexpression enhanced IL-18 synthesis in co-cultures of HUVECs and BxPC-3 or Capan-2 cells,17\n285,SOTAILGFLOSIN,PROLIFERATION,Sotagliflozin was tested to investigate its effect on cell proliferation,14\n1703,CRART16,GASTRIC CANCER,\"**CRART16** is a prognostic marker and therapeutic target in **gastric cancer**.  Research indicates that overexpression of CRART16 is associated with advanced tumor stages and a poorer prognosis for patients. \n\",14\n1887,HRMEC,PROLIFERATION,HRMECs showed increased proliferation in high glucose condition,14\n1903,H22954,AML SAMPLES,H22954 was tested on AML samples in the study,14\n287,HIGH GLUCOSE,HYPOXIA,\"High glucose and hypoxia are factors that inhibit cell viability, proliferation and migration in the study of sotagliflozin's effects on angiogenesis\",13\n1873,PTX3,HRMECS,\"HRMECs are the cells used to test PTX3 expression and effects on cell growth, migration, and tube formation\",13\n1907,H22954,DUAL-LUCIFERASE REPORTER GENE ASSAY,H22954 was used to study the relationship between H22954 and PDGFA in a reporter gene assay,13\n1908,H22954,HALF-LIFE ASSAY,H22954 was tested for its effect on protein half-life using a half-life assay,13\n1916,CELL LINES,COX-2,COX-2 gene is used to study gastric cancer cell lines,13\n284,SOTAILGFLOSIN,CELL VIABILITY,Sotagliflozin was tested to investigate its effect on cell viability,12\n1619,ENDOTHELIAL TP,COX-2,\"Endothelial TP expression induces COX-2 activation\nCOX-2 activation is induced by endothelial TP expression\",11\n1621,COX-2,IN VIVO ANGIOPGENESIS ASSAYS,COX-2 activation is induced by endothelial TP expression,11\n2004,HYPOXIC CONDITIONS,PROLIFERATION,Preconditioning stem cells under hypoxic conditions can improve proliferation,11\n117,KNOCKOUT MICE,MIGRATION,Knockout mice were used to study migration,10\n276,DIABETIC CONDITIONS,HIGH GLUCOSE,High glucose levels mimic diabetic conditions,10\n1709,CRART16,VEGFD,CRART16 promotes VEGFD expression,10\n1886,HIGH GLUCOSE,PTX3 SIRNA,High glucose condition combined with PTX3 siRNA further strengthened HRMECs' abilities,10\n1912,GASTRIC CANCER,CELL LINES,Gastric cancer cells are studied using cell lines,10\n395,HYPOXIA,CELL CULTURE,Hypoxia is a condition that can be simulated in cell culture,9\n1602,BXPC-3,CELL VIABILITY,BxPC-3 cells' viability was analyzed,9\n1603,CAPAN-2,CELL VIABILITY,Capan-2 cells' viability was analyzed,9\n1704,CRART16,GASTRIC CANCER CELLS,\"CRART16 overexpression promoted proliferation, angiogenesis, and bevacizumab resistance in vitro\",9\n1707,CRART16,MIR-122-5P,CRART16 downregulates miR-122-5p,9\n1879,PTX3,TUBE-FORMING ABILITY,PTX3 can affect tube formation in response to FGF,9\n945,METTL3,GASTRIC CANCER,\"Overexpressed in human GC, promoting tumor cell proliferation and angiogenesis\",8\n1874,PTX3,FGF,\"FGF can induce proliferation, migration, and tube-forming ability in HRMECs, which is affected by PTX3\",8\n1875,PTX3,KI67 IMMUNOFLUORESCENT STAINING,PTX3 is being studied in relation to cell proliferation using Ki67 staining,8\n1876,PTX3,ERK PHOSPHORYLATION,PTX3 can affect ERK phosphorylation levels,8\n1877,PTX3,FIBROBLAST GROWTH FACTOR (FGF)-INDUCED PROLIFERATION,PTX3 can affect cell proliferation in response to FGF,8\n2000,HUMAN ADIPOSE-DERIVED STEM CELLS,STEM CELLS,hADSCs are a type of stem cell,8\n2003,STEM CELLS,HYPOXIC CONDITIONS,Preconditioning stem cells under hypoxic conditions can be beneficial,8\n281,SOTAILGFLOSIN,C2C12 SKELETAL MUSCLE CELLS,Sotagliflozin was tested on C2C12 skeletal muscle cells to investigate its effects on angiogenesis,7\n393,IN VITRO STUDY,HYPOXIA,The study was conducted under hypoxic conditions,7\n835,CELL COUNTING KIT-8 (CCK-8),CELL VIABILITY,CCK-8 assay measures cell viability,7\n1620,ENDOTHELIAL TP,ANGIOGENIC CAPACITY,Endothelial TP overexpression or knockdown/knockout affects the angiogenic capacity of endothelial cells in vitro and in vivo,7\n1880,HRMECS,SCRATCH-WOUND MIGRATION ASSAY,HRMECs are used to test the effect of PTX3 on cell migration,7\n1881,HRMECS,TUBE FORMATION EXPERIMENTS,HRMECs are used to test the effect of PTX3 on tube formation,7\n1889,HRMEC,TUBE-FORMING,HRMECs showed increased tube-forming abilities in high glucose condition,7\n1910,PDGFA,CELL LINES,PDGFA protein expression was detected in cell lines,7\n2016,REGENERATIVE THERAPY,STEM CELLS,Regenerative therapy uses stem cells for treatment,7\n652,HYPOXIA,BLOOD VESSEL FORMATION,Hypoxia can affect blood vessel formation,6\n2020,ANGIOGENIC GROWTH FACTORS,PATHOLOGIES,Growth factors are used to treat pathologies,6\n2022,ANGIOGENIC THERAPEUTICS,PROCEDURES,Treatments that use angiogenic properties to improve outcomes,6\n398,CELL CULTURE,PROLILYL,Prolyl is a type of amino acid that can be used to mimic the effect of hypoxia on HIF-1α expression,5\n2021,ANGIOGENIC GROWTH FACTORS,PROCEDURES,Growth factors are used to improve outcomes for procedures,5\n274,ENDOTHELIAL PROGENITOR CELLS,DIABETIC CONDITIONS,EPC function is impaired under diabetic conditions,4\n1267,DIABETIC WOUNDS,LOWER EXTREMITY AMPUTATION,Diabetic wounds can lead to lower extremity amputation,4\n1268,DIABETIC WOUNDS,DEATH,Diabetic wounds can lead to death,4\n1618,LIPID MEDIATOR,IN VIVO ANGIOPGENESIS ASSAYS,Lipid mediator profiling is used to study the effects of endothelial TP overexpression or knockdown/knockout on the angiogenic capacity of endothelial cells in vitro and in vivo,4\n1710,FOS,VEGFD,Increased FOS expression leads to increased VEGFD expression,4\n946,METTL3,ADAMTS9,Downstream effector of METTL3,3\n1617,LIPID MEDIATOR,FUNCTIONAL CELL ANALYSIS,Lipid mediator profiling is used to study the effects of endothelial TP overexpression or knockdown/knockout on the angiogenic capacity of endothelial cells in vitro and in vivo,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_11c6b33e5e4279054022bcbaa4345c88b1b21c8df27ef11f5a01497b00daaaa1_v2"}